Target: Cancer Podcast: Recent Episodes
xCures
Target: Cancer Podcast is a channel where people can learn about all the newest technologies and treatments for cancer. Combining technology, doctors, and patients together in a way that is collaborative, informative, and enlightening. In TARGET: Cancer Podcast, Sanjay and guests will be talking about the future of cancer treatment. We are going to address questions like, what does that future look like, and why isn’t it here now? Everyone is terrified of cancer, but if we are able to understand it better and know how to win the battle, it’s going to give patients and doctors the assurance they desire.
CMS just proposed rules that could decide who gets paid for AI in healthcare, and that's a bigger deal than another “better algorithm” story. Dr. Sanjay Juneja and Dr. Douglas Flora talk with Jordan Johnson (radiation oncology, healthcare finance, compliance and law) about what's actually in the proposal and what happens once it lands. Topics: when does AI actually count as a billable clinical service. Why getting paid also means getting watched more closely. Hospitals leaning toward integrated platforms over one-off point solutions. What to do now, before the rule locks in. Still just a proposal, not law yet, so we should say that somewhere.
Eric Lefkofsky, Founder and CEO of Tempus AI, joins Dr. Sanjay Juneja and Dr. Doug Flora to explore how artificial intelligence, real-world data, genomic sequencing, and emerging technologies like organoids are reshaping oncology. From reducing diagnostic errors to matching patients with more effective therapies, AI is transforming how clinicians make decisions and how researchers develop the next generation of treatments. The conversation examines why healthcare adoption has lagged behind technological progress, the growing role of patient-driven intelligence, and how connected data may help eliminate thousands of preventable cancer deaths each year. Eric also shares his vision for AI-powered clinical decision support, digital twins, drug development, and the future relationship between physicians and intelligent systems.
What happens when artificial intelligence becomes a trusted partner in patient care? Healthcare leaders are increasingly exploring how AI can help clinicians make faster, more informed decisions while reducing administrative burden and improving patient outcomes. But deploying AI in medicine requires balancing innovation, trust, regulation, and clinical judgment. In this conversation, Dr. Scott Penberthy, Dr. Lindsey Cotton, and Dr. Doug Flora explore the future of cancer care, precision medicine, digital twins, physician adoption, implementation science, and the role of AI in supporting—not replacing—clinical decision-making. From cancer screening and treatment selection to workflow automation and predictive modeling, they discuss what healthcare may look like when every clinician has access to intelligence that helps them see what was previously invisible.
Cancer is often most treatable when it's found early—but what if we could detect it before symptoms ever appear? Advances in genomics, blood-based biomarkers, and artificial intelligence are giving researchers new ways to identify cancer earlier, understand disease at a deeper level, and move beyond one-size-fits-all treatment approaches. In this conversation, Dr. Scott Penberthy, Dr. Lindsey Cotton, and Dr. Doug Flora explore how emerging technologies are reshaping cancer detection, precision medicine, drug discovery, and clinical decision-making. They discuss the growing role of multimodal AI, the promise of next-generation sequencing, and why the future of healthcare may depend on finding patterns humans simply cannot see on their own. The goal isn't just better technology—it's earlier intervention, more personalized care, and better outcomes for patients.
Cancer treatment may be missing one of the body’s most important biological signals: circadian rhythm. In this conversation, sleep neurologist Dr. Anne Marie Morse explains how sleep timing, inflammation, immune function, and wearable data could fundamentally reshape cancer care. Emerging research suggests the timing of immunotherapy, chemotherapy, and even sleep disruption itself may influence treatment response, survival, and recurrence risk. The discussion explores chronotherapy, circadian genes, microbiome interactions, and how AI-driven analytics may help clinicians move beyond episodic care toward continuous, personalized monitoring.
AI is transforming healthcare at an unprecedented pace—but the biggest risks aren’t clinical, they’re legal, operational, and systemic. From data center infrastructure and environmental impact to reimbursement shifts and agentic AI workflows, the stakes are rising fast. New models from major tech players are poised to influence care delivery—and even get reimbursed based on outcomes—raising critical questions about ownership, liability, and control. Where does responsibility fall when AI drives decisions? How should hospitals evaluate vendors, data sources, and infrastructure risks? And what happens when automation outpaces regulation?
AI is making remarkable progress in healthcare — but translating that progress into real clinical impact is more complex than it seems. In this episode, we break down the State of Clinical AI in 2026, separating signal from noise and exploring what’s actually working today.
AI is exploding in healthcare — but most startups still fail. In this episode of the AI & Healthcare Podcast, Dr. Sanjay Juneja speaks with innovation leaders Dr. Bernardo Perez-Villa and Dr. Peter Alperin about the reality of building successful medical technology in 2026. Hundreds of AI tools have FDA clearance, billions have been invested in digital health, and yet hospitals still struggle to adopt new technology. Why?
Care is delivered every day in American hospitals, but getting paid for that care has become a battle. Denials, prior authorization, billing complexity, and rising costs have created a financial crisis behind the scenes of modern medicine. Insurance companies use automation to control payments, while hospitals struggle to keep up. Now AI is entering the fight. Dr. Sanjay Juneja and Dr. Douglas Flora speak with Monique Lappas, Founder and CEO of Qualify Health, about the growing war over who pays for care and how intelligent automation is helping providers recover lost revenue, reduce patient debt, and keep hospitals from closing.
Mental health is now central to high-quality cancer care, yet access, diagnostic precision, and scalability remain major gaps. In this in-depth discussion, clinical and innovation leaders explore how artificial intelligence can shift mental health care from reactive support to precision-driven, proactive intervention. The conversation examines AI as a clinical signal amplifier that enhances human judgment without replacing it. Topics include objective diagnostics, functional brain mapping, digital phenotyping, therapeutic bots, longitudinal monitoring, and how AI can better match patients to the right level of care at the right time. The discussion also addresses real-world implementation challenges in oncology and health systems, including workforce shortages, equity, and clinical oversight.
AI in healthcare is accelerating fast—but adoption without governance is risk. In this conversation, oncology and health policy leaders break down how clinicians and health systems should evaluate emerging AI tools: what FDA clearance vs approval really means, why “not FDA-approved” doesn’t automatically mean unsafe, and how laboratory-developed tests (LDTs) are already embedded in everyday care. We also explore real-world evidence, model drift, and why implementation—not innovation—is the true bottleneck for safe scale. If you’re assessing AI in imaging, diagnostics, clinical decision support, or workflow automation, this is your framework for asking smarter questions and protecting patients.
Digital twins are moving from engineering into healthcare and the implications are profound. From oncology decision-making to clinical trials and personalized medicine, virtual human twins could reshape how clinicians predict outcomes, reduce toxicity, and tailor treatment. Dr. Sanjay Juneja and Dr. Doug Flora are joined by digital twin leaders Jim St. Clair and Professor James Fargason to explore how real-time data, AI, and system-level modeling can move medicine beyond population averages toward individualized care. This conversation unpacks what a true digital twin requires, why data quality and interoperability matter, and how digital twins may accelerate drug development, improve trial design, and reduce moral injury for clinicians.
Continuous monitoring is reshaping oncology. CEO of AION Biosystems, Sam Barend, joins Dr. Sanjay Juneja, Dr. Douglas Flora, and Dr. David Penberthy to explore how long‑term physiologic tracking, AI‑driven insights, and clinically validated wearables are improving outcomes for patients at high risk of complications. The conversation highlights FDA pathways, reimbursement realities, and the promise of simpler, signal‑focused monitoring that detects patterns earlier and supports safer treatment continuity.
Cancer care isn't what it used to be—and that's exactly why Dr. Douglas Flora just wrote a book about it. Are you ready to understand how AI is transforming oncology? In this episode of AI and Healthcare, host Dr. Sanjay Juneja and co-hosts Dr. Douglas Flora and Dr. Deborah Pat are joined by special guest Dr. Chadi Nabhan—author, educator, and passionate advocate for cancer education—to discuss Doug's newly released book on AI in cancer care, currently #1 in oncology on Amazon. Doug wrote it because he feels "desperate" to share how dramatically cancer treatment is changing. The physicians reflect on how far oncology has come from mixing chemotherapy by hand to AI-powered precision medicine. Whether you're a healthcare professional, cancer survivor, or curious about AI in medicine, this conversation offers an honest look at where oncology is headed. New episodes every two weeks.
AI is changing everything from policy to the patient room. In this AI&H roundtable, Dr. Doug Flora, a leading voice in oncology innovation, joins Dr. Sanjay Juneja, Dr. Debra Patt, and Mika Newton to tackle what’s really holding back AI adoption in healthcare. They explore Medicare’s AI prior auth model, the role of clinical decision support, and why strong change management is the linchpin of real progress. Dr. Flora shares leadership lessons and insights from the front lines.
Healthcare is shifting fast, and AI is at the center of the storm. In this powerful roundtable, Dr. Sanjay Juneja hosts xCures CEO Mika Newton, Dr. Debra Patt of Texas Oncology, and Dr. Jason Hill of Ochsner Health to break down how AI is already reshaping access, risk, and care delivery. From ambient scribes to open-source models, from liability concerns to mental health triage—this conversation covers what matters.
What is patient design, and why does it matter in modern healthcare? Dr. Bertalan Meskó, Director of The Medical Futurist Institute, explains why patient involvement is critical to innovation and trust. Patient-centered design shifts the model from making decisions for patients to making decisions with them. This co-creation approach ensures better outcomes and more effective digital health solutions.
Could AI soon become a required element of value-based care? Dr. Stephen Speicher from Flatiron Health explores a near-future scenario where insurers may require AI tools to be used in clinical workflows to qualify for reimbursement.
In this forward-looking discussion, Dr. Speicher breaks down how AI could be both a cost burden and a quality catalyst—and why its integration into value-based care models might become non-negotiable.
Should patients be able to opt out of AI in their care? Dr. Stephen Speicher, Head of Clinical Oncology and Safety at Flatiron Health, dives into the evolving ethics of informed consent as AI becomes increasingly embedded in medical workflows. From regulatory trends to future standards of care, he examines how clinicians and patients can navigate transparency, autonomy, and shared responsibility.
What if your future self could guide your decisions today? Dr. Bertalan Mesko, Director of The Medical Futurist Institute, shares a surprisingly effective strategy: vision writing. By imagining yourself in the future and striking “deals” with future versions of yourself, you can create emotional clarity and motivation in the present.
Predictive AI and wearable tech are changing healthcare from reactive to proactive.
This clip explores how real-time data and AI models can detect illness before symptoms emerge.
Jordan Johnson of Bridge Oncology and Dr. Sanjay Juneja discuss the future of medicine—from CMS reimbursements to remote monitoring and predictive diagnostics.
What will the future of healthcare really look like? Medical futurist Dr. Bertalan Meskó reveals how foresight, patient design, and prompt engineering are reshaping the landscape of care. In this interview with oncologist Dr. Sanjay Juneja, learn how to prepare for multiple futures, integrate AI tools effectively, and lead cultural change in medicine.
Should AI in health records be considered a medical device? Emily Lewis, an AI thought leader, compares the U.S. FDA and U.K. NHS approaches to AI regulation in healthcare. She shares how global discrepancies affect responsible AI implementation and what leaders must do to stay compliant. Discover why local adaptation and ongoing education are critical.
Interoperability isn’t just a buzzword—it’s a broken promise. Jordan Johnson, founder of Bridge Oncology, explains how fragmented systems, outdated data, and lack of standardization are driving financial loss and patient harm. From mismatched EMRs to payer confusion, this interview exposes the operational and policy-level stakes.
How do we make healthcare AI both safe and scalable? Dr. Stephen Speicher, Head of Clinical Oncology and Safety at Flatiron Health, shares how responsibility for AI safety must be shared across developers, deployers, clinicians, and health systems. He breaks down use-case-specific risks, informed consent challenges, and the risk of widening healthcare inequities.
Why are digital health companies still struggling to connect with EHRs—even after federal mandates? Dr. Ben Rosner breaks down results from a national survey exploring API integration challenges, from proprietary workarounds to endpoint confusion. He also previews a new survey aimed at measuring real progress since the 21st Century Cures Act.
Healthcare data interoperability isn’t just about EMRs—it’s about patient survival, equity, and system sustainability. Jordan Johnson, MSHA, Founder of Bridge Oncology, breaks down the true scope of interoperability, from payer systems to AI-enabled radiotherapy. In this dynamic conversation with Dr. Sanjay Juneja, they explore how structured data, legal frameworks, and real-time analytics can reshape value-based care and prevent patient harm.
Is AI helping—or harming—the next generation of doctors? UCSF's Dr. Ben Rosner shares how AI is reshaping medical education in 2025. From tutor bots to clinical skill assessments, he explores the opportunities and pitfalls. Discover what 'de-skilling' means, and why educators need smart guardrails to guide AI integration.
AI is transforming discharge documentation. Dr. Ben Rosner of UCSF breaks down how large language models (LLMs) perform compared to physicians—and what that means for safety, education, and clinical workflows. Learn what “LLM as jury” could mean for quality control and how AI might de-skill future doctors if we're not careful.
AI is no longer just for clinicians. Emily Lewis, an AI thought leader, explains how AI is becoming a partner in patient care. From gamified self-care tools to multimodal education, she breaks down how technology can foster better communication and empower patients to take control of their health. She also explores the regulatory and data challenges involved in scaling AI for patient use. Featuring Dr. Sanjay Juneja. Learn more about Emily: https://www.udemy.com/user/emily-lewis-77/ Host: https://sjunejamd.com/
"Views expressed by Dr. Juneja and Emily Lewis are solely their own and are not attributable to xCures, Tempus, or any of our guest's affiliations."
Disruptive innovation isn’t always what it seems—especially in healthcare. Bernardo Perez-Villa, Senior Innovations Engagement Partner at the Cleveland Clinic, shares a revealing look at the myths behind “first-in-class” innovation. Learn how startups create disruption, why big players wait to buy instead of build, and how to use Christensen’s framework to identify true disruption.
Why do so many digital health startups collapse? Dr. Bernardo Perez-Villa explains how a lack of real market validation derails innovation before it starts. Learn how to perform meaningful primary and secondary market research—from asking the right questions to clinicians to scanning Reddit and PubMed for real-world proof of need.
What separates scalable healthcare AI from hype? Dr. Bernardo Perez-Villa, Cleveland Clinic's Senior Innovations Engagement Partner, breaks down how to validate AI ideas, assess product-market fit, and build business models that survive reimbursement hurdles. Hosted by Dr. Sanjay Juneja.
Why rely on one method when three are better? Ezra CEO Emi Gal explains how combining imaging, liquid biopsy, and biomarkers creates a superior cancer screening protocol. He also shares how AI enables longitudinal tracking of lesions, reducing false positives and patient anxiety. Learn what makes Ezra’s approach uniquely effective in the fight against cancer.
Discover how Ezra uses FDA-cleared AI to transform MRI imaging. CEO Emi Gal explains how Ezra Flash speeds up scan times while improving quality, and how Ezra Assist aids radiologists with accurate annotations. Their AI-powered process makes full-body cancer screening possible in just 22 minutes—for under $500. Learn how this innovation is redefining medical imaging from acquisition to interpretation.
Can patients and clinicians be fairly rewarded for sharing healthcare data? Rajeev Ronanki, CEO of Lyric, discusses a future where AI-enabled tools empower community oncology practices with personalized digital agents. He outlines how reimbursement models can support physicians scaling their care using AI, and why rewarding patient data sharing is both ethical and economically sound.
Ezra CEO Emi Gal breaks down how AI is revolutionizing full-body MRI cancer screening. Learn how FDA-cleared tools accelerate scan time, assist radiologists, and empower patients with easy-to-understand reports—all for just $499. Discover why early detection matters, especially for younger adults, and how Ezra is scaling access to lifesaving diagnostics.
Rajeev Ronanki, CEO of Lyric and former Elevance Health executive, unpacks what the FDA’s AI initiative—Elsa—really means for drug innovation and regulation. Rajeev outlines how the agency can use data it already has to drive smarter, faster decisions. He draws powerful parallels to autonomous vehicles and urges the FDA to embrace AI while maintaining scientific rigor.
Trust in AI cannot exist without ethics - and ethics cannot exist without confronting data bias. Discover how artificial intelligence can become a force for safety, fairness, and innovation in healthcare when designed with integrity from the ground up.
In this compelling exchange, Dr. Sanjay Juneja (sjunejamd.com) interviews Rajeev Ronanki (LinkedIn), CEO of Lyric, to uncover how AI can be engineered to identify bias, self-evaluate decisions, and evolve into a trusted collaborator in clinical care. They reveal practical strategies for bias detection, the vision of an "AI Hippocratic Oath," and why ethics must precede deployment - especially in medicine.
Healthcare leaders, CIOs, CMOs, engineers, and innovators will gain critical insight into governance frameworks that future-proof AI adoption.
Rajeev Ronanki, CEO of Lyric and author of You and AI, joins Dr. Sanjay Juneja to discuss a radical rethinking of payment in healthcare. Instead of upgrading legacy systems, Rajeev proposes bypassing them using trusted AI agents that mediate between EMRs and payers. They explore real-time adjudication, the importance of trust and transparency, and how scalable AI tools can serve even community clinics. Learn how AI is reshaping healthcare finance from the ground up.
AI in healthcare brings breakthroughs - but also new legal and ethical risks. Who’s responsible when an AI-assisted diagnosis leads to harm? The licensed physician? The hospital? The tool’s developer? As AI becomes embedded in clinical workflows, this question becomes unavoidable. In this conversation, Mika Newton, CEO of xCures (https://www.linkedin.com/in/mikanewton/), interviews Dr. Colleen Lyons, clinical research ethicist (https://aicommons.champlain.edu/people/colleen-p-lyons/), to unpack AI liability in modern healthcare. They explore frameworks for ethical responsibility, institutional risk, informed deployment, and the leadership competencies needed to navigate intelligent failure.
AI is reshaping clinical care, but can we apply trusted bioethical principles to its rapid adoption? This discussion explores how the Belmont Report’s three ethical pillars - autonomy, beneficence, and justice - remain essential as AI tools enter diagnosis, decision-making, and patient communication in modern healthcare. Hosted by Mika Newton, CEO of xCures, with expert insights from Dr. Colleen Lyons, a leading clinical research ethicist, the discussion covers informed consent in AI-assisted care, transparency versus explainability, and the ethical implications of asymmetrical power in AI systems. Gain a deeper understanding of how healthcare leaders can navigate AI integration while safeguarding patient rights and institutional trust.
Is AI in healthcare racing toward a crash? Discover what happens when innovation outpaces oversight, and why unchecked growth could lead to another industry meltdown. Mika Newton, CEO of xCures (https://www.linkedin.com/in/mikanewton/), and Dr. Colleen Lyons, clinical research ethicist at Champlain College (https://aicommons.champlain.edu/people/colleen-p-lyons/), unpack the consequences of deregulation and the unintended barriers of over-regulation. They explore the ethics, governance models, and leadership competencies required to navigate the volatile, uncertain, complex, and ambiguous (VUCA) world of AI-driven healthcare. Learn why compliance alone won't future-proof your organization, how to embed ethical frameworks that actually work, and how to recognize when you're stuck in a hype cycle with no real value.
AI transforms how healthcare data is structured, analyzed and applied to clinical decision-making in life sciences. Discover how leading experts harness artificial intelligence to streamline clinical workflows, enhance data quality and accelerate actionable insights for healthcare providers and diagnostic organizations. Mika Newton, CEO of xCures, and Rajiv Haravu, SVP of Product Management at IMO Health, break down practical frameworks for applying AI to complex patient records, from medical coding to interoperability strategies. Understand how AI-driven tools empower healthcare teams to navigate vast medical datasets, improve patient care pathways and support value-based care delivery.
AI is changing healthcare - but are we prepared for the hidden risks? From undermining critical thinking to damaging the human connection between providers and patients, AI’s unintended consequences deserve attention. Mika Newton (CEO, xCures) talks with Dr. Spencer Dorn (Vice Chair, UNC Department of Medicine) about the deeper risks AI poses across clinical care, system operations, and provider responsibilities. They explore overlooked dangers: the erosion of professional judgment, reliance on AI-generated summaries, and the threat to personal relationships in medicine. This is essential viewing for leaders navigating AI implementation in health systems.
Dr. Colleen Lyons, a clinical research ethicist with FDA experience, breaks down how ethics must evolve to meet the realities of AI in healthcare. From data bias to transparency, autonomy, and organizational responsibility, she offers an unflinching perspective on where we’re falling short - and what must change. Hosted by Mika Newton. Connect with Dr. Lyons: Champlain College Profile. More AI & Healthcare insights: xCures.com
AI is transforming how clinicians handle information, starting with one of the most urgent issues in healthcare: too few providers, too much data, and not enough time. This conversation explores how AI can support physicians by summarizing patient records and medical literature, reducing burnout, and improving clinical decision-making. Hosted by Mika Newton, CEO of xCures (https://www.linkedin.com/in/mikanewton/), the interview features Dr. Spencer Dorn, Vice Chair & Professor of Medicine at the University of North Carolina (https://www.linkedin.com/in/spencerdorn/). He shares powerful insights into AI’s current and future role in healthcare delivery—beyond scribing—to information synthesis, predictive analytics, and ultimately better clinical decisions.
AI scribes are transforming how clinical notes are written, relieving physicians from time-consuming documentation and unlocking more patient-focused care. In this video, we explore what AI scribes really do, how they vary in capability, and which features actually move the needle in clinical practice. Hosted by Mika Newton, CEO of xCures (https://www.linkedin.com/in/mikanewton/), and featuring Dr. Spencer Dorn, Vice Chair & Professor of Medicine at the University of North Carolina (https://www.linkedin.com/in/spencerdorn/), the interview outlines how AI scribes differ by integration depth, impact on workflows, and their role in improving documentation accuracy, coding, and even downstream reimbursement.
Precision in surgery doesn’t start in the operating room - it starts with the data. Learn how advanced imaging, outcome-linked datasets, and AI-driven insights are reshaping surgical decisions and reducing repeat procedures. Dr. Sanjay Juneja speaks with Adrian Mendes, CEO at Perimeter Medical Imaging AI, to explore the critical relationship between imaging data and post-surgical outcomes in breast cancer care. They break down how image-based machine learning models improve real-time margin assessment, lower costs, and lead to better patient results.
Missed margins and repeat surgeries drive up healthcare costs and stretch critical resources. OCT technology offers a path to smarter imaging and fewer reoperations, cutting costs while improving outcomes. Dr. Sanjay Juneja hosts Adrian Mendes, CEO of Perimeter Medical Imaging AI, to unpack how intraoperative OCT can drastically lower re-excision rates in breast cancer surgery. They explore the ripple effect this has on healthcare economics - from reduced OR time and insurance payouts to stronger patient survival rates. You’ll learn how data-backed imaging aligns both clinical and financial priorities.
AI scribes promise relief from clinical documentation fatigue - but what are their limitations, hidden risks, and true return on investment? In a landscape saturated with new scribing technologies, understanding which tools integrate meaningfully with EHR systems and which merely transcribe surface-level dialogue is critical for healthcare leaders. Hosted by Mika Newton, CEO of xCures (https://www.linkedin.com/in/mikanewton/), this discussion features Dr. Spencer Dorn, Vice Chair and Professor of Medicine at UNC (https://www.linkedin.com/in/spencerdorn/), offering clear insights into how AI scribes impact physician workflow, coding accuracy, and care quality. The conversation examines where current tools fall short, highlights the importance of personalization and contextual summarization, and explores how AI may shift the clinician-patient relationship.
Healthcare is shifting fast. If you’re not actively learning how to use AI, you're already behind. This discussion reveals how to get the most value out of AI in clinical care, even if you're just starting. Host Dr. Sanjay Juneja (https://sjunejamd.com) sits down with physician-entrepreneur Dr. Harvey Castro (https://www.linkedin.com/in/harveycastromd/) to unpack the critical steps healthcare professionals can take right now to stay relevant and lead with AI. They discuss how to build your AI fluency, what content to follow, how to vet sources, and why a passion for patient care should drive your tech adoption. This is essential viewing for clinical leaders, health IT teams, diagnostics innovators, and telehealth executives ready to make informed decisions in a data-driven world.
AI-assisted imaging is enhancing the precision of breast-conserving surgery by enabling surgeons to reduce re-excisions, preserve healthy tissue, and make more informed intraoperative decisions. Learn how real-time AI models trained on high-resolution optical coherence tomography (OCT) images are transforming how clean margins are assessed during lumpectomies. Adrian Mendes, CEO of Perimeter Medical Imaging, joins Dr. Sanjay Juneja, The OncDoc, to unpack the technological, clinical, and operational implications of using AI to support breast cancer surgery. They cover practical use cases, data strategy, FDA pathways, and cost-savings that matter to hospitals, payers, and diagnostic partners. If you're a provider, technologist, or decision-maker looking to scale smarter surgical care, listen now for valuable insight into what’s next in surgical AI.
AI isn’t replacing healthcare workers - it’s preserving the workforce and extending its reach. From robotic support that reduces physical strain on aging nurses to ambient scribing that eliminates after-hours charting, AI is stepping in where capacity is stretched thin. This conversation explores how AI tools are already shifting care models, enabling clinicians to manage more patients with greater precision and less burnout. Dr. Sanjay Juneja interviews Dr. Harvey Castro, MD, MBA, about practical, near-term applications of AI across clinical environments, including diagnostics, home-based monitoring, and decision support. They discuss real use cases, ethical implications, and a future where physicians spend more time connecting with patients - not keyboards.
Discover how agentic AI is transforming clinical workflows by enabling intelligent digital twins of healthcare professionals that learn, adapt, and act autonomously. This breakthrough supports faster decision-making, reduces bottlenecks, and expands the reach of clinical expertise across provider systems, telehealth, labs, and diagnostic settings. Dr. Sanjay Juneja hosts Dr. Harvey Castro, who explores how agentic systems integrate with wearables, streamline emergency care, and deliver timely medical insights. You’ll learn how scalable AI agents enhance operational efficiency and knowledge-sharing without compromising the human touch.
Healthcare systems face a critical question: build custom AI tools tailored to their workflows, or buy ready-made solutions? This video unpacks the operational, financial, and clinical factors that inform that decision, including insights on cost, customization, integration, and innovation in patient-centered AI. Dr. Sanjay Juneja (https://sjunejamd.com/) interviews Dr. Harvey Castro (https://www.linkedin.com/in/harveycastromd/) to explore the nuances of AI adoption in hospital systems. They break down the value of federated learning, ambient scribe technologies, cultural considerations in care, and how to ensure AI models support rather than replace clinical decision-making. If you're in health system leadership, clinical informatics, operations, or product strategy, this discussion offers frameworks to guide smarter, sustainable AI investments.
AI agents are changing how clinical decisions are made, workflows are optimized, and care is delivered across hospitals, labs, and telehealth systems. Learn how these tools can scale medical expertise, streamline bottlenecks, and improve patient outcomes—without replacing the human element. Hosted by Dr. Sanjay Juneja and featuring expert insights from Dr. Harvey Castro, this interview explains how digital twins, ambient AI, and agentic systems can support clinical judgment, reduce burnout, and personalize care at scale. You’ll also hear practical guidance on whether to build or buy AI tools, how to structure healthcare-specific data, and what integration actually looks like in high-pressure environments. If you’re in healthcare leadership, IT, operations, or product development, this discussion provides frameworks and real-world examples you can act on now.
AI is reshaping rare disease treatments by accelerating drug repurposing, identifying therapeutic opportunities, and unlocking actionable insights hidden in clinical data. Discover how innovative frameworks and technology platforms are helping healthcare leaders, diagnostic companies, and telehealth providers uncover new treatment pathways faster and more efficiently. Dr. Sanjay Juneja (https://sjunejamd.com/) speaks with Dr. David Fajgenbaum (https://www.linkedin.com/in/davidfajgenbaum) about the ethical imperative of using AI-driven drug repurposing to address underserved rare conditions and the growing potential to surface overlooked therapies. Gain practical insights on decision-making, data analysis, and scalable solutions that can impact patient care.
Unlock faster, smarter drug repurposing with open-source data that arms clinicians and researchers with actionable insights. This discussion explores how cutting-edge AI and knowledge graphs are transforming access to potential therapies by ranking 4,000 approved drugs against thousands of diseases - all in record time. Host Dr. Sanjay Juneja speaks with Dr. David Fajgenbaum, Co-founder of Every Cure, to reveal how their platform delivers 75 million computed drug-disease scores directly into the hands of healthcare providers worldwide. Learn how this approach accelerates clinical decision-making, supports evidence-based research, and breaks down barriers to innovative care strategies.
AI prediction is transforming patient care by accelerating how life-saving treatments are identified, repurposed, and delivered to those in need. Discover how cutting-edge data analysis can uncover overlooked therapies and drive faster clinical decisions that impact real-world outcomes. Dr. Sanjay Juneja interviews Dr. David Fajgenbaum, co-founder of Every Cure, to reveal actionable strategies for leveraging artificial intelligence in healthcare systems. Learn how AI-powered frameworks are optimizing treatment selection, guiding clinical workflows, and informing executive decisions across provider networks, telehealth, laboratories, and diagnostics.
The idea that artificial intelligence can uncover life-saving treatments hidden in plain sight is no longer science fiction. In a healthcare system that often favors costly innovation over accessible solutions, using AI to repurpose existing drugs offers a path to faster, affordable breakthroughs. Join Dr. Sanjay Juneja and Dr. David Fajgenbaum, co-founder of Every Cure, as they reveal how AI is accelerating the identification of overlooked therapies for rare and complex diseases. Learn about the critical frameworks behind drug repurposing, how predictive models like Matrix are reshaping disease treatment, and why open-source collaboration could transform healthcare delivery. If you are a physician, healthcare executive, engineer, or healthcare IT leader, this discussion offers essential insights into the future of clinical decision-making.
Accurate clinical insights depend on more than just throwing a large language model at a problem. Data normalization and structured medical concepts shape how AI delivers precision in healthcare coding, clinical decision support, and patient care. Mika Newton, CEO of xCures, and Rajiv Haravu unpack how proprietary medical content, editorial policies, and knowledge graphs provide essential context that LLMs alone cannot offer. Learn why healthcare organizations still rely on medical code sets for reimbursement, accurate ICD-10 coding, and decision-making workflows - and how AI-driven agents may soon accelerate ontology creation, dictionary migration, and terminology mapping. Discover actionable frameworks and expert perspectives on leveraging AI in clinical environments to minimize hallucinations, enhance accuracy, and maintain relevance in a rapidly evolving healthcare landscape.
Data normalization in healthcare isn't just complex – it's mission critical. When a simple lab result like hemoglobin A1C can be recorded under half a dozen different names, clinicians face real obstacles in tracking trends, managing care, and making timely decisions. Mika Newton, CEO of xCures, and Rajiv Haravu, SVP of Product Management at IMO Health, break down why non-standardized data jeopardizes care quality, public health insights, and patient safety. From mismatched lab terms to inconsistent clinical narratives, they explore how definition decay and evolving medical language complicate interoperability and downstream data uses. Learn the frameworks and methodologies IMO Health uses to combat variability – leveraging clinical terminologists, curated content releases, and continuous surveillance of healthcare terminology. Discover how structured and narrative data normalization impacts providers, IT leaders, and healthcare operations.
Healthcare data is messy, inconsistent, and buried in narrative. AI sounds like the solution. Until it isn’t. In this episode of AI and Healthcare, xCures CEO Mika Newton speaks with Rajiv Haravu, SVP of Product Management at IMO Health, to dissect the real-world challenges of data normalization. From inconsistent documentation of basic lab tests to extracting insights from billions of unstructured notes, Rajiv explains why AI alone falls short - and how precision tools, editorial standards, and clinically-informed design can bridge the gap.
Emergency rooms are overwhelmed, not just by medical crises, but by the fallout of systemic failures. A growing number of patients are showing up with issues rooted in poverty, housing instability, and food insecurity. AI is helping change that. By connecting underserved patients to billions in unclaimed public benefits, new tools are offering a path to preventative care that begins outside the hospital walls. Dr. Alister Martin explains how AI is being used to bridge the gap between policy and care, reduce avoidable ER visits, and ease pressure on a healthcare system that spends billions treating conditions that could be prevented. When patients get access to the support they already qualify for, outcomes improve - and so does the bottom line.
As AI becomes a core part of modern medicine, the way we train future doctors may be due for a serious rethink. Empathy and adaptability, not just chemistry and memorization, could define what makes a good physician in the age of augmented intelligence. With language models becoming standard tools for both patients and providers, skills like prompting, critical thinking, and emotional intelligence may soon matter more than traditional academic benchmarks.
What started with a rabbit heart in a physiology lab led to a career focused on preventing strokes through early detection of atrial fibrillation. A Stanford cardiologist shares how that moment sparked a lifelong interest in cardiac rhythms and how today’s wearables can now detect AFib through simple, continuous monitoring, long before symptoms appear. This shift from reactive care to early detection marks a major step forward in heart health, powered by straightforward algorithms and a growing role for AI in predicting cardiovascular risk.
What if your smartwatch could detect a heart condition before you ever felt a symptom? Stanford cardiologist Dr. Euan Ashley reveals how AI and wearables are quietly reshaping the future of healthcare, from spotting silent strokes to redefining what “normal” health looks like. Why do we service our cars and inspect bridges, but wait for our bodies to break down before acting? That question sets the stage for a deep dive into proactive medicine, where tools like the Apple Watch are already catching atrial fibrillation early, and continuous health monitoring could alert us to problems years in advance. Beyond the wrist, AI is transforming everything from clinical documentation to access to specialist care. But big questions remain: Can algorithms be truly equitable? Will personalized prevention ever reach everyone? From ambient AI scribes to the end of “one-size-fits-all” medicine, this is a glimpse into healthcare’s next chapter, where your heart might be talking long before you notice.
AI is only as good as the data behind it, and in healthcare, that data is often messy, outdated, and biased. As systems create digital versions of patients, known as twins, the risks increase when data deteriorates or is used without informed consent. Understanding how data breaks down over time, how it's mislabeled or misused, and why clean, well-governed data matters is essential to creating safer, smarter tools that actually work for people, not against them.
Health data is deeply personal, yet it rarely belongs to the individual. Hospitals, labs, tech platforms, and researchers hold the information that defines our health, often without clear consent or transparency. As data grows more valuable, the people it comes from are often excluded from its benefits. Shifting ownership, improving access, and creating real control are essential steps toward giving individuals the power they deserve over their own health information.
AI systems are no longer just tools, they’re starting to act on our behalf, powered by our data and often without our awareness. These digital twins, built from lab results, genomes, and behavior patterns, are shaping real decisions in healthcare and beyond. When that data is fragmented, outdated, or biased, the risks multiply. Building systems rooted in truth, transparency, and trust is the only way to ensure these technologies serve us - not replace us.
The future of healthcare data could go in two very different directions. On one side is a system where consent is a checkbox, your data is used without your knowledge, and decisions about care, credit, and access are made by algorithms trained on broken information. On the other is a future where individuals own their data, control how it’s used, and benefit from its value. The choice isn’t science fiction, it’s already being made. Now is the time to decide which future we build.
Emergency rooms are stretched thin, and AI might be the key to making them work better, for patients and clinicians. From ambient AI that cuts down on hours of documentation to large language models that surface critical patient history in seconds, new tools are helping doctors focus on care instead of paperwork. These innovations could ease burnout, reduce delays, and transform how decisions are made in the moments that matter most.
We’re entering a future where AI isn’t just supporting healthcare - it’s shaping decisions, influencing outcomes, and acting on our behalf, often without us even realizing it. These systems are becoming digital twins of real people, powered by everything from lab results to behavior patterns, and the implications are massive. Jason Alan Snyder from Super Truth explains how your health data is being used to build digital versions of you - ones that can make decisions without your knowledge. He breaks down why this matters, how bad data leads to bad outcomes, and what it would look like to actually take control of your data. It’s a powerful look at what’s really happening behind the scenes in healthcare, and why it affects all of us.
Tackling healthcare costs requires both human connection and smarter use of technology. Dr. Alister Martin emphasizes the importance of trust, the power of patient navigators, and why AI is quickly becoming essential. With a focus on workforce upskilling and sustainable reimbursement models, there’s a clear path to reducing ER visits, improving outcomes, and making care more affordable.
AI has the potential to transform healthcare, but adoption remains slow. Outdated IT infrastructure, strict data policies, high implementation costs, and concerns around bias and model performance all stand in the way. Scaling AI in hospitals requires more than just promising tools - it demands infrastructure that supports ongoing governance, transparency, and real-world impact.
Healthcare is drowning in inefficiency - 80% of data is noise, and clinicians waste precious time on tasks that don’t improve patient outcomes. But AI is flipping the script. Imagine diagnosing lung cancer in seconds instead of digging through hours of records, or boosting revenue (RVUs) while actually enhancing care quality. Uncover the real barriers to AI adoption and how new platforms are cutting through vendor lock-in to make AI tools accessible in weeks, not months. From radiology to care coordination, AI isn’t just the future - it’s the lifeline healthcare needs today.
Millions of dollars are being wasted in healthcare every year—not because of a lack of resources, but because people aren’t accessing the help that already exists. AI is starting to change that. By streamlining access to underused benefit programs, AI can help patients avoid unnecessary ER visits, reduce hospital strain, and cut costs across the healthcare system. Dr. Alister Martin shares how his work at Link Health is using AI to bridge the gap between patients and public resources, with real-world results backed by recent clinical trials. It’s a powerful example of how smart technology can drive both financial and human impact in medicine.
Healthcare costs are rising, but AI could be the key to fixing the system. Beyond improving patient care, AI has the potential to reduce administrative burdens, streamline workflows, and lower overall costs. Dr. Alister Martin has spent years at the intersection of medicine and social change, exploring how technology can make healthcare more efficient and accessible. This conversation looks at how AI-driven solutions can address both the financial and social challenges facing the healthcare industry.
AI adoption in healthcare comes with complexities, from regulatory hurdles to the challenge of building secure, scalable systems that align with hospital needs. Finding the right balance between innovation and data privacy is key to ensuring these technologies can be effectively integrated into medical environments.
AI is transforming healthcare by streamlining medical workflows, enhancing drug development, and driving more efficient, data-driven solutions. Krish Ramadurai shares insights on AI-native health tech, digital pathology, and the challenges of scaling automation in biotech, highlighting the impact of technology on the future of medicine.
Picking the right drugs is a high-stakes game. Get it right more often than the competition, and the rewards are massive. Miss a few, and you’re out. So how do top investors and biotech leaders make smart bets? Understanding what pharma actually wants, securing multiple key advocates, and strategically managing risk are all part of the playbook. From clinical-stage assets to investor-backed decision-making, this deep dive unpacks how biotech companies position themselves for success—and what separates the winners from the rest.
AI in healthcare is evolving fast, but how much of it is real progress—and how much is just hype? While AI-driven tools are reshaping clinical workflows and decision-making, many solutions struggle with integration, regulatory hurdles, and real-world adoption. The real winners? Companies that master proprietary data, streamline physician workflows, and build AI solutions that actually work within the constraints of healthcare. From clinical automation to imaging and diagnostics, the impact is undeniable—but replacing doctors? Not happening anytime soon. Where is AI making a real difference, and where is it just noise? Let’s break it down.
The future of healthcare is evolving rapidly, and technology is playing a bigger role than ever. Pelu Tran shares insights on how AI, data-driven decision-making, and digital tools are reshaping patient care and the way doctors work. From improving clinical workflows to making healthcare more accessible, these innovations are changing the industry in real time. We also explore the challenges of integrating new technology, the balance between automation and human expertise, and what the next decade of healthcare could look like. How will these advancements impact both patients and medical professionals?
AI is transforming biotech, making drug development more predictable. From improving drug discovery to tackling the translatability crisis, new advancements are optimizing clinical success rates. Learn why many AI-designed drugs fail, how human data is reshaping the field, and why repurposing shelved assets might be the next big opportunity in pharma.
Waiting until cancer is already formed before acting? That approach needs to change. Science now has the tools to detect the earliest warning signs—long before a tumor even develops. Breakthrough technologies like AI-driven monitoring and implantable sensors could transform how we detect disease, tracking subtle biological changes in real time. Instead of periodic tests that might miss critical moments, continuous screening could catch cancer in its earliest whispers—when prevention is still possible. If we already know the steps leading to cancer, why aren't we stopping them? The answers might surprise you.
Understanding lab results can be overwhelming, but what if AI could help make sense of the data and improve patient care? Dr. Sanjay Juneja and David Norris explore how artificial intelligence is reshaping healthcare—reducing administrative burdens, detecting conditions like iron deficiency, and streamlining workflows. They also discuss how AI is giving doctors more time with patients by handling routine tasks, easing burnout, and enhancing provider-patient relationships. AI is transforming healthcare by improving efficiency, enhancing patient care, and raising important ethical questions about its role in medical practice.
Cancer detection is long overdue for a revolution. Current screening methods miss too much, cost billions, and often lead to false positives. But what if we could catch cancer at the very first cell—before it ever becomes a threat? A breakthrough technology could make that possible. AI, continuous monitoring, and implantable devices are reshaping how we detect disease, moving beyond outdated methods toward real-time, 24/7 tracking. Imagine a future where cancer is stopped before it even starts. Is this the next big leap in medicine?
Early cancer detection can save lives, yet traditional treatments often focus on late-stage disease. This episode explores the critical need for a shift in approach—studying human cells directly, improving model systems, and building a comprehensive tissue repository to better understand cancer at its earliest stages. Dr. Azra Raza shares insights on key differences in cancer progression between children and adults, along with the ethical and practical challenges of early intervention.
Mika Newton and Dr. Nigam Shah explore whether healthcare technology and AI are addressing the right problems. They discuss the tendency to focus on easy solutions like using language models to respond to patient messages, which may not save time as expected. The conversation highlights the need to redefine goals and use AI for innovative approaches rather than just replicating existing tasks done by humans. They emphasize increasing access and efficiency in healthcare, like using AI for triaging patients and educational interactions, which can free up resources and potentially double service capacity.
Mika Newton speaks with Dr. Nigam Shah, a Stanford professor and Chief Data Scientist at Stanford Healthcare, about AI’s role in healthcare. They discuss evaluating AI’s impact on patient care, the challenges of benchmarking AI models, and the importance of using real-world data. The conversation explores how AI can enhance clinical decision-making, the need for well-defined research questions, and strategies for selecting the right data to improve healthcare outcomes.
AI is reshaping healthcare, from clinical workflows to drug discovery and the rise of full-stack biotech companies. But what are the real challenges, and where is AI falling short? Mika Newton sits down with Krish Ramadurai from AIX Ventures to break down the complexities of AI in healthcare, the importance of domain expertise, and the push to automate clinical development. They also discuss how startups can navigate the industry’s regulatory landscape and what investors are looking for in AI-driven healthcare solutions. Whether you're in biotech, investing, or just curious about the future of AI, this discussion offers valuable insights.
Join Dr. Sanjay Juneja and Columbia University professor Dr. Azra Raza in an in-depth discussion about the transformative potential of AI and technology in early cancer detection. Dr. Raza shares her insights on how continuous monitoring and innovative technologies could find cancer at the 'first cell stage,' long before traditional methods. Learn about her journey from pediatric oncology to establishing one of the richest tissue repositories, and discover how AI-powered implantable devices could revolutionize the future of healthcare. This episode sheds light on the untapped possibilities in proactive cancer care and the critical shift needed to focus on early detection.
This episode features Nigam Shah discussing the sustainability of AI in healthcare, focusing on challenges in development, validation, and regulation. The conversation explores the limitations of current AI models, the evolving role of governance, and the need for localized validation to ensure accuracy and relevance.
In this episode, Mika Newton speaks with Dr. Nigam Shah, a professor at Stanford and Chief Data Scientist at Stanford Healthcare, about the challenges and opportunities of AI in healthcare. They discuss the sustainability of AI development, the complexities of regulation, and the importance of localized validation. The conversation explores how AI can enhance clinical decision-making, optimize healthcare resources, and expand patient access while addressing barriers in implementation, governance, and data sharing.
This podcast episode explores the intersection of AI and healthcare, focusing on drug development, repurposing, and access to medical treatments. Mika Newton speaks with Bob Battista about the challenges of sharing pharmaceutical data, regulatory barriers, and how AI could enhance clinical decision-making. They discuss real-world data, patient knowledge, and the role of technology in optimizing treatment pathways. The conversation also touches on privacy laws, governance, and the potential for AI to empower patients with better access to medical insights. Viewers will gain a deeper understanding of how innovation and policy changes could improve healthcare outcomes.
Mika Newton and Bob Battista explore how AI could reshape healthcare by giving patients greater control over their medical decisions. They discuss the potential for AI to process vast amounts of clinical data, improve access to relevant treatments, and bridge gaps in health literacy. The conversation also raises important questions about data sharing, patient autonomy, and the future of AI-driven support in medicine.
Mika Newton and Bob Battista discuss how AI is shaping healthcare decision-making. They explore its role in analyzing clinical evidence, updating guidelines dynamically, and personalizing treatment recommendations. The conversation also highlights challenges like regulatory restrictions and data silos that limit AI’s full potential in the industry.
Drug repurposing offers a way to find new treatments using existing medications, but regulatory hurdles and financial disincentives often prevent progress. Mika Newton and Bob Battista examine the challenges of data sharing in the pharmaceutical industry, the high costs of clinical trials, and why companies hesitate to pursue niche indications. They also explore potential policy solutions that could encourage collaboration and make more life-saving treatments accessible to patients.
Mika Newton and Tom Neyarapally discuss how AI is changing the landscape of drug discovery. They examine the role of machine learning, patient data, and computational tools in accelerating the process, reducing costs, and improving the chances of developing effective treatments. The conversation covers how AI-driven screening, drug repurposing, and real-world data integration are helping to overcome traditional challenges in bringing new therapies to patients faster. They also examine the potential for collaboration between AI technology and clinical expertise to drive future breakthroughs in medicine.
Mika Newton and Tom Neyarapally explore how advancements in AI are accelerating the development of new algorithms, improving target discovery, and enhancing high-throughput screening. The conversation highlights the challenges and opportunities in aggregating innovative technologies, the convergence of AI tools in healthcare, and the potential for personalized and economically viable drug development.
Explore how AI is transforming drug discovery by enabling the rapid screening of billions of molecules and identifying new uses for existing drugs. This approach integrates patient data with advanced tools to predict effective treatments for diseases with unmet medical needs, significantly reducing the time and cost of development.
In this episode, Dr. Sanjay Janeja and Dr. Debra Patt discuss AI in healthcare. They cover its applications in cancer care, from improving diagnostics and treatment decisions to enhancing patient education and real-time symptom management. The conversation also highlights AI's potential in drug discovery, reducing healthcare costs, optimizing administrative workflows, and addressing the challenges of data integration and biases in AI systems. Together, they emphasize the importance of collaboration between clinicians and digital tools to deliver better, more efficient patient care.
Dr. Sanjay Juneja and Dr. Debra Patt discuss patient data in healthcare, including de-identification, data aggregation for research, and the evolving role of AI. They explore how communication systems and real-world evidence improve care delivery, reduce ER visits, and enhance efficiency for healthcare providers.
Mika Newton and Tom Neyarapally discuss how advancements in data, AI tools, and computing power are transforming drug discovery, particularly in oncology. They explore patient-centric approaches, in silico screening, and strategies to reduce the time and cost of bringing new treatments to market.
An overview of ASCO's approach to artificial intelligence in cancer care, focusing on responsible use, transparency, and the importance of keeping physicians at the center of decision-making. The clip discusses guidelines, challenges like biases and model limitations, and how AI can complement personalized care.
Dr. Debra Patt and Dr. Sanjay Juneja explore how AI is reshaping healthcare, focusing on its impact on physicians and patient care. Discover how AI tools are seamlessly integrated into care delivery, from enhancing cancer diagnostics and automating clinical documentation to improving administrative efficiency. Learn about AI-powered scribe services that reduce doctors’ workloads, enabling real-time patient notes, better disease management, and enhanced communication with caregivers. Additionally, we explore AI's role in drug discovery, clinical trial optimization, and streamlining insurance approvals.
Dr. Juneja and Dr. Patt discuss the financial implications of AI adoption, how tools like ambient listening and real-time monitoring can enhance patient care, and the role of AI in educating patients to manage treatment toxicities. Plus, they dive into the advancements in drug discovery and clinical trials, where AI is paving the way for more efficient and personalized therapies.
In this episode, Dr. Sanjay Juneja is joined by Mika Newton, CEO of xCures, to explore how AI is transforming the future of medicine. Together, they discuss tackling critical challenges like resource shortages, improving patient triaging, and leveraging data for smarter, faster decision-making. Mika shares his unique insights on how technology is reshaping healthcare systems and the exciting opportunities ahead. Don’t miss this engaging conversation —and stay tuned for a surprising reveal at the end!
Join Dr. Sanjay Juneja, known as the OncDoc, as he discusses the complex intersection of endocrinology and oncology with Dr. Afreen Shariff, an expert endo-oncologist from Duke University. This episode explores the often-overlooked endocrine side effects of cancer treatments, such as steroids and immune therapies, and how they impact patient quality of life. Dr. Shariff shares insights on managing hormonal imbalances, the importance of specialized care, and how platforms like Citrus Oncology are democratizing access to expert opinions and care. Discover how patients can better navigate the challenges of cancer treatment and thrive, supported by comprehensive, multi-specialty care. If you or a loved one are facing cancer treatment, this episode is essential listening.
In this episode of the Target Cancer Podcast, Dr. Sanjay Juneja sits down with Dr. Tim Showalter, Chief Medical Officer at Artera, to explore the transformative role of AI in personalizing cancer treatment. Dr. Showalter shares insights on how advanced AI tools are helping clinicians make more precise decisions, reducing overtreatment, and improving patients’ quality of life. Together, they discuss the moral and medical challenges of balancing aggressive cancer therapies with patient-centered care and the promise of AI in guiding better, data-driven outcomes.
In this engaging episode of the 'Target: Cancer Podcast,' Dr. Sanjay Juneja discusses the future of healthcare data with Therasa Bell, President, CTO, and co-founder of Kno2. Covering themes of healthcare inefficiencies, the importance of data sharing, and the critical need for innovation, this conversation dives deep into ways to tackle pressing concerns such as the aging population, provider shortages, and the sustainability of healthcare systems. You'll discover why data is seen as an underlying theme essential for solving these inherent issues and what measures are being taken at state and federal levels to improve the situation.
In this eye-opening episode, Dr. Sanjay Juneja teams up with leading experts Dr. Jason Fung and Dr. Thomas Seyfried to reveal the shocking truth about what really drives cancer growth. Forget everything you thought you knew—this isn’t just about genetics! They dive into the powerful connection between diet, insulin, and metabolism, and how controlling sugar and inflammation might hold the key to stopping cancer in its tracks. If you’ve ever wondered whether cancer can be "starved," this is the conversation you need to hear.Tune in for a mind-blowing discussion that could revolutionize cancer treatment!
Dr. Lim takes us through the evolution of personalized cancer therapy, starting from animal trials and advancing to human treatments. He explains how artificial intelligence is playing a critical role in creating precise and effective treatment plans in oncology. Explore the impact of AI in transforming cancer care by offering more personalized therapies, and how precision medicine is shaping the future of patient outcomes.
Join Dr. Sanjay Juneja as he talks with Dr. Sam Blackman about advancements in Pediatric Neuro-Oncology. Dr. Blackman shares his journey from philosophy to medicine, discusses innovative treatments for pediatric brain cancer, and explores the role of AI in neuro-oncology. Discover insights into the latest therapies and the future of brain cancer treatment for children in this episode. Gain a deeper understanding of the challenges and breakthroughs in treating pediatric brain tumors.
In this episode of the Target: Cancer Podcast, Dr. Sanjay Juneja dives deep into the latest developments in colorectal cancer with Michael Sapienza, CEO of the Colorectal Cancer Alliance. Michael shares his personal journey from professional musician to leading cancer advocate, inspired by his mother’s battle with the disease. Discover the urgent need for innovative treatments and how advancements in AI and data sharing can revolutionize colorectal cancer care. Learn about cutting-edge screening methods, the critical importance of early detection, and the ongoing efforts to improve funding and research for colorectal cancer prevention.
The podcast episode features Dr. Sanjay Juneja interviewing Dr. Robert Den, a Harvard and Yale-trained physician and radiation oncologist. Dr. Den discusses the importance of trust in the patient-physician relationship and its impact on cancer treatment decisions. He emphasizes the need for personalized care, considering patients' individual circumstances and goals. Dr. Den introduces the innovative "DaRT" (Diffusing Alpha Radiation Therapy) technology, which targets tumors with alpha radiation, demonstrating promising results across various cancer types. He explains how this approach can offer new hope and treatment options, especially for patients with challenging cancer cases. The conversation highlights the potential of DART therapy to improve patient outcomes and quality of life.
Dr. Chris Apfel explores innovative AI technology in cancer treatment, emphasizing early detection and personalized therapies. By utilizing real tissue testing to determine optimal drug responses, this method aims to enhance patient outcomes. Discover how this advancement is transforming cancer care and advancing precision medicine. Join Dr. Apfel on the Target: Cancer Podcast to delve into the future of customized treatments.
Discover the future of healthcare with Dr. Daniel Kraft on the Target: Cancer Podcast. Explore AI, wearables, and digital health in cancer care, and the potential of multiomics data and predictive analytics to revolutionize patient outcomes. Join the discussion on integrating cutting-edge advancements into everyday practice and navigating the evolving healthcare landscape. Don't miss this riveting exploration of technology, medicine, and innovation.
Investigative reporter Kristina Marusic delves into the connection between environmental exposures and cancer risk, sharing her sister's diagnosis and the effects of everyday chemicals. She emphasizes reducing pesticide exposure, filtering air and water, and using safer personal care products. Marusic advocates for regulatory changes and encourages listeners to urge lawmakers to prioritize cancer prevention. Tune in to discover how small lifestyle changes can significantly lower cancer risk.
Dr. David Braun discusses the exciting advancements in cancer vaccines and immunotherapy. He explains how the immune system can be harnessed to target and eliminate cancer cells, particularly in kidney cancer. He also discusses the potential for preventive vaccines and the future of curative treatments for cancer. This episode offers a fascinating glimpse into the cutting-edge research and possibilities in cancer immunotherapy.
Dr. Amit Kumar discusses the groundbreaking concept of a vaccine for cancer. He explains how they have identified "retired proteins" that are only produced during specific periods of life, such as lactation, and reappear when cancer cells arise. By vaccinating individuals after they no longer need these proteins, the immune system can be trained to target and destroy cancer cells. Dr. Kumar shares their progress in developing a vaccine for breast cancer and other types of cancers as well.
Dr. Sanjay Juneja interviews David Hysong and Katherine Arline from Shepherd, a precision oncology platform. They discuss the limitations of traditional cancer treatment guidelines and the need for a more personalized approach. Shepherd uses multiomic data, including RNA sequencing, to assess a patient's unique tumor characteristics and recommend tailored therapies. They also consider collateral medications and potential side effects.
Dr. Sanjay Juneja interviews Dr. Musti Kadhim about the exciting advancements in cancer treatment and the role of AI in improving patient care. They discuss the challenges of treating pancreatic and glioblastoma cancers, the potential of hypofractionation in radiation therapy, and the use of AI in precision medicine. Dr. Kadhim also explains the importance of data sharing and the ethical considerations surrounding AI in healthcare.
In this episode, we will discuss about the role of free circulating tumor DNA testing in early cancer detection, the current limitations of existing cancer screening modalities and the need for more proactive approaches to cancer care. Dr. Venstrom explains how Grail's technology works, using a blood test to detect abnormal patterns of DNA shedding from tumors. He emphasizes the importance of the cancer signal of origin and how it can guide targeted diagnostic and therapeutic interventions.
In this episode, Dr. Sanjay Juneja and Dr. David Penberthy discuss the role of radiation in cancer care and its effectiveness. Dr. Penberthy explains the different types of radiation therapy and how they are used to treat various types of cancer. They also explore the potential of combining radiation with immunotherapy and the exciting advancements in the field, the importance of a multidisciplinary approach to cancer treatment and the need for ongoing research and innovation.
In this episode, Dr. Sanjay Juneja discusses the impact of herbal supplementation, dietary supplementation, and diets on cancer outcomes. He is joined by Dr. Krystle Zuniga and Dr. Laura Kerns, who provide valuable insights based on their expertise in cancer nutrition. The episode covers topics such as the importance of protein and vitamins, the role of mushrooms and supplements and the benefits of a plant-based diet, also addresses common questions about red meat, dairy, and the gut microbiome.
Dr. Sanjay Juneja and rhinologist Dr. Henry Barham delve into taste receptors' intriguing role in cancer control and immune health. They examine t2r receptors, uncovering their ties to innate immunity and anti-cancer properties. Dr. Barham shares insights on bitterness sensitivity, COVID-19 outcomes, and a taste test for personalized diets and immune stimulation. This episode provides a fresh perspective on the significance of taste receptors in overall health.
Dr. Sanjay Juneja interviews Dr. Christy Kesslering, about the impact of metabolic health and diet on cancer, how cancer cells upregulate insulin and glucose receptors, and how a ketogenic diet can starve cancer cells by reducing glucose levels. They also explore the potential of ketosis and the importance of optimizing mitochondrial health. The conversation touches on the role of growth hormone, the potential benefits of exogenous ketones, and the need for personalized cancer therapies.
Explore the intersection of medicine and cannabis on this enlightening episode of the Target Cancer Podcast! This special edition features Codi Peterson, pediatric pharmacist and chief science officer of Cannigma. He shares insights on THC, cannabis, and marijuana. He strives to bridge the knowledge gap between medical professionals and cannabis. Discover the legal landscape of medical cannabis and its reported benefits. Subscribe now for your dose of medical insights!
Join Dr. Sanjay Juneja and Dr. Doug Flora on the Target Cancer Podcast to explore AI's role in shaping the future of oncology. Discover how AI is set to revolutionize clinical applications, enhance patient care, and provide more precise treatment profiles. A must-watch discussion for healthcare enthusiasts!
In this edition of the Target: Cancer podcast, Dr. Sanjay Juneja delves into the game-changing impact of Artificial Intelligence in cancer treatment, together with Scott Penberthy, who is the Director of Applied AI at Google. Get insights into the potential of AI to transform medical practices, improve patient care, and streamline oncology. Explore how AI is ushering in a new cancer treatment era and discover how it will revolutionize healthcare. Tune in to learn more!
In this episode of the Target Cancer Podcast, Dr. Sanjay Juneja and Douglas Feil, the Chief Program Officer for the National Breast Cancer Foundation, have a heartfelt conversation in honor of October's Breast Cancer Awareness Month. Inspired by his mother's battle with cancer, Doug shares his experiences and insights on navigating the challenges of cancer, the importance of screenings, and how to support our loved ones during their battles.
In the 50th podcast episode, Dr. Sanjay Juneja welcomes Kelly Thomas, Bethany Webb, and Erin Soto, who share their experiences and insights as cancer survivors and advocate for a healthy mindset during cancer treatment. In this very interesting episode, we discuss the challenges of receiving clear and accurate information about cancer diagnoses and treatments, the importance of doctor-patient communication, and the evolving landscape of cancer therapies.
In this Target Cancer podcast episode, Dr. Corrie Painter, a survivor of angiosarcoma, shares her non-traditional journey and the challenges of a rare disease diagnosis. Her story highlights the need for greater awareness and support for rare cancers and diseases. Dr. Painter also shares some insights on the "Count Me In" initiative and how it accelerates cancer research by connecting patient data with the research community.
In this episode of Target: Cancer Podcast, Dr. Sanjay Juneja and Dr. Chadi Nabhan delve into the Roundup & lymphoma connection, explore glyphosate's role, discuss oxidative stress theories, and demystify the mysteries the complexities of blood cancers. Discover factors beyond luck influencing cancer.
In this informative video, Dr. Paul Kent sheds light on fibrolamellar carcinoma, a rare and often misdiagnosed liver cancer that mainly affects young adults. Understand the challenges faced by patients with fibrolamellar carcinoma and stay updated on recent successes in obtaining treatment approvals. Discover the DNAJB1-PRKACA mutation, treatment advancements, and the power of hope in facing this condition.
Join us as we explore gastrointestinal (GI) knowledge with renowned expert Dr. Michael Byrne. With extensive medical and AI expertise, Michael provides a unique perspective on early cancer diagnosis and the challenges in detecting GI cancers. From colon to stomach and esophageal cancer, discover advancements in screening techniques and the role of AI in improving outcomes. Uncover the potential of AI solutions in revolutionizing GI healthcare and catching cancer early.
In this episode, Sanjay welcomes Dr. Ely Benaim from SonALAsense and discusses a groundbreaking technology targeting brain cancer. Dr. Benaim explains the concept of sonodynamic therapy, which introduces a novel approach to disrupting cancer's energy source by exploiting the cancer cell's hunger for 5-ALA, ultimately causing its death. This approach, without toxicity or side-effects, provides hope in treating GBM, DIPG, and other cancers.
In this second part of the interview with Dr. Jason Fung, we delve into a new paradigm for understanding cancer and a fresh approach to treatment. Our conversation uncovers groundbreaking insights that challenge traditional views on cancer, how it evolves, and how to fight it. Join us as we take back control in the fight against cancer with Dr. Jason Fung.
Join us as we dive deep into the fascinating world of metabolic health and its impact on cancer. Renowned expert Dr. Jason Fung delves into the intricate connection between hyperinsulinemia, obesity, breast cancer, and beyond. Discover the truth about fats, and learn if traditional or shorter intermittent fasting durations work best for cancer prevention and weight loss. Uncover the complexities of insulin resistance and its impact on cancer development. Don't miss this eye-opening discussion.
In this episode, Dr. Thomas Seyfried discusses metabolic approaches to cancer. Learn how depriving cancer cells of fermentable fuels like glucose and glutamine can starve and kill them. Challenge the genetic disease model and discover the impact of ketosis on mitochondrial health. Uncover the truth about cancer as a metabolic, not genetic, disease. Empower yourself with the knowledge to combat cancer through metabolic strategies and learn about the dangers surrounding us: processed foods.
Dr. Sanjay Juneja interviews Dr. John Whyte, the Chief Medical Officer of WebMD and bestselling author, to discuss cancer prevention and the impact of lifestyle on cancer risk. They discuss how genetics are only responsible for a small percentage of cancers and that lifestyle and environmental factors have a greater influence. Dr. Whyte emphasizes that people should not feel responsible for their cancer diagnosis, but they can take steps to reduce their risk.
In this episode, we discuss community oncology and social media’s role in sharing knowledge. The OncBrothers, Dr. Rahul and Dr. Rohit Gosain, share their experiences working in the field and using social media to connect with colleagues. They emphasize the importance of better access to genomic testing and targeted therapies and the need for patients to ask their oncologists about these options.
Michael Levin, a biologist studying regenerative and cellular regeneration, believes cancer arises when cells disconnect from the network that keeps them working towards larger goals. Cells become like amebas, rolling back to a single-cell lifestyle with limited goals. He explains his work with the planarian flatworm as the holy grail of regenerative medicine with incredibly cancer-resistant and immortal properties.
Discover the Truth About Cancer: Debunking Misconceptions with Dr. Sanjay and Dr. Joseph Zundell. Learn about cancer cell adaptation, comprehensive treatment plans, and new developments in cancer treatments like Enhertu and bispecific antibodies. Also, explore immunotherapy, cancer therapy testing on mice, and personalized treatment options.
In this episode we have Dr. William Li, a renowned physician, scientist and author. Dr. Li and Dr. Sanjay discuss how the body has many natural defense mechanisms against cancer. One such defense is DNA, and its ability to suppress cancer cells. Self-care and listening to one's body cannot be overstated in the fight against cancer. Dr. Li urges oncologists to listen closely to their patients to provide the best care. Additionally, small changes in one's diet, like incorporating pears, can improve gut health and affect cancer treatment.
This week's guest is Dr. Paul Billings, a board-certified internist, renowned researcher, and clinical geneticist. Dr. Billings and Dr. Juneja talk about new methods of early detection of cancer and dive into Dr. Billings's recent research endeavor on exosomes and how they function to identify potentially cancerous cells from a single blood draw, even before symptoms occur. This revolutionary technology aims to redefine cancer screening as we know it.
In this episode, we talk with Laura Towart, Founder & CEO of Vivian Therapeutics, a company that revolutionizes cancer treatment by personalizing it to each patient's unique tumor using an army of 500,000 fruit fly avatars. They use a patient's genes against all FDA-approved drugs to identify the drug combinations for people with advanced cancer. We also learn about their tool, TuMatch, which can quickly find treatments for colorectal cancer patients.
This week's guest is Dr. Sandip Patel, a professor of medical oncology from UC San Diego. Dr. Patel and Dr. Juneja talk about the gut microbiome, how it affects our health, and especially how it relates to cancer. In this very interesting episode, Dr. Patel shares some insights about his studies on bacteria that can impact cancer treatments. We also learn about antibiotics, probiotics, acid reflux, and the relationship between diet and cancer.
This episode's guest is "America's Favorite Doctor,” Dr. Laura Purdy, a board-certified Family Medicine Physician. Dr. Purdy joins Dr. Juneja to talk about telehealth and how it's changing patients' lives by increasing access to care. In this episode, we learn how to find a doctor from the comfort of our own home and how screenings and prescriptions work on these virtual healthcare visits. On the topic of cancer, Dr. Purdy also shares her perspective on genetic tests for cancer prevention.
Our guest this week is Mark Shapiro, COO of xCures. Dr. Sanjay and Mark talk about the importance of accessing and structuring patient medical records and how they can be used to help guide treatments and improve patient care. In this episode, learn about advancements in AI software that are now transforming the oncology sector and how xCures is harnessing this technology and making it available to every cancer patient and oncologist in the US.
Dr. Sanjay Juneja had the pleasure of talking with Dr. Pedro Barata, Associate Professor of Medicine at Case Western University and a leading expert in genitourinary tumors. Dr. Barata addresses the topic of kidney cancers, most specifically, renal cell carcinoma (RCC), and clarifies their subtypes and the ways we can treat them. In this episode, we also learn about new therapies, like immunotherapy, and how they are helping prostate cancer patients.
Our guest this week is Dr. Siddhartha Mukherjee, a physician, researcher, and Pulitzer Prize winner. Dr. Mukherjee and Dr. Juneja talk about a new approach to fighting cancer, by analyzing the internal metabolism of the cancer cell so that we can prevent cancer growth by starving it. Dr. Mukherjee shares his learnings on how specific diets - targeting amino acids and other nutrients - in combination with other therapies, can help patients control their cancer.
Our guest this week is Dr. Jay McCracken, Neurosurgical Oncologist at Piedmont Atlanta Brain Tumor Center. Dr. Juneja talks with Dr. McCracken talk about the scary topic that is brain cancer. Can meningiomas be cancerous? Why makes it Glioblastoma so challenging to treat? Dr. McCracken shares some insights on tumor resection and the techniques used to achieve functional preservation. Learn about GammaTile to precisely deliver radiation and how it can dramatically improve the treatment of GBM in comparison with external beam radiation.
Our guest this week is Dr. Ian Walters, CEO of Portage Biotech. Dr. Juneja talks with Dr. Walters to explain how we can potentially educate our own immune system to kill cancer cells and then retain that education to prevent future recurrences. And what if we could create a drug to impact multiple cancers - via existing checkpoint inhibitors or pathways? Watch this episode to find out about the science that is being developed right now.
This episode's guest is Dr. Susan Dent, medical oncologist at Duke Cancer Center and president of the International Cardio-Oncology Society (IC-OS). Dr. Dent and Dr. Juneja talk about the world of cardio-oncology. What is cardio-oncology? How cancer therapies can impact cardiovascular toxicity? And, most importantly, can we prevent it? These are some of the questions that Dr. Dent addresses in this episode and help us understand.
Our guest this week is Dr. John Hood. Dr. Hood, together with Dr. Sanjay, talk about gene mutations on cancer growth and all the advances in next-generation sequencing that are transforming the treatment of cancer as we know it. If you have heard of the terms: NGS, genomic sequencing, or molecular profiling, but are unsure what they mean, how they work, and - especially - how you can benefit from them, this is the episode for you.
Our guest this week is Dr. Cliff Reid. Dr. Reid shares some exciting information about an innovation that can revolutionize the way that cancer is treated - by testing different cancer drugs and seeing which ones work or not within 48h. Watch Dr. Sanjay be mind-blown while Dr. Reid explains the science behind this innovation and the potential it can have in the life of cancer patients and their oncologists.
Our guest this week is Dr. Anjali Malik. Dr. Juneja and Dr. Malik talk about the different screening techniques and answers common concerns about breast cancer. In this episode, we learn about the differences between mammograms, ultrasounds, and MRIs and how/when each procedure is recommended. We also learn about breast augmentation, genetics and how it impacts the detection of breast cancer. Watch the full episode to learn from Dr. Malik's insights and expertise.
Dr. Sanjay Juneja sits down with Dr. Suresh Nair. Dr. Nair is a medical oncologist at the Lehigh Valley Topper Cancer Institute and focuses on melanoma, kidney cancer (renal cancer), and sarcoma. They talk about the different types of immunotherapies available. Cancers like melanoma and sarcoma have been "scary" cancers for a long time because there weren't many treatments available. But now, several types of therapies are available, so much so that melanoma isn't considered as scary as it used to be.
Our guest this week is Santosh Kesari, a neurologist and neuro-oncologist at Saint John's Cancer Institute. Dr. Sanjay & Dr. Santosh talk about the different types of brain tumors and what is happening NOW in brain cancer.
Dr. Sanjay & Dr. Santosh agree on the importance of sleep when it comes to health and just how vital the immune system really is when it comes to fighting off disease and cancer.
More importantly, Dr. Santosh discusses some of the different types of exposure that can cause brain cancer as well as several of the new treatments available to brain cancer patients.
Dr. Sanjay Juneja speaks with Derek Albert, the President of Concerned Foundation for cancer research. Derek’s primary goal is to fund young cancer investigators. Sanjay and Derek talk about research, philanthropy, the role music has in cancer, and a variety of ways for the average person to make an impact in cancer treatment.
Dr. Sanjay Juneja had the pleasure of talking with Greg Simon, the former President of the Biden Cancer Initiative. Dr. Sanjay and Greg talk about the various dilemmas cancer patients run into and the very real consequences that come as a result. Because of Greg's experience, he sheds light on the serious gap we have of providing proper care and treatment to ALL cancer patients. The good news is that Greg Simon has some plans to radically change the healthcare system for the better!
Dr. Ricky Brown is a Double Board Certified Aesthetic Plastic Surgeon who performs cosmetic and reconstructive procedures in Scottsdale, Arizona. He sits down with Dr. Sanjay Juneja, and they talk about the different types of mastectomies and how far we’ve come in surgery for breast cancer. One of these options are nipple sparing mastectomies, and they are incredible! Dr. Ricky Brown believes this option for women is one of the best options available because all the skin is spared and the implant looks the most natural. His goal is to educate, inspire, and motivate as many people as possible by giving them these novel surgery options and empowering them with the knowledge they need to make the healthiest decisions for their lives.
Dr. Greg Bailey, CEO and Co-Founder of Juvenescence, has been heavily involved in anti-aging for several years now. He's discovered, along with the help of his colleagues, the main contributors of cancer and more importantly, how to live a longer, healthier life. From bio hacks to how your BMI can dramatically affect your risk of getting cancer, Dr. Bailey and Dr. Sanjay discuss it.
Dr. Sanjay Junega sits down with Dena Goldberg who is a genetic counselor practicing in Los Angeles. She received her Masters in Genetics and Hereditary Cancers.
First and foremost, only about 10-15% of cancers are hereditary, meaning they were passed down from a parent. This means that 85-90% of cancer patients did not get it from their parents.
There are many different genetic tests out there, and Dena cautions people on only using one option as it could not be complete. The most valuable aspect of speaking to a genetic counselor is the counseling aspect. The natural concern that comes with getting cancer affects people in ways they don’t even realize. There is a lot of psychosocial and emotional stress that comes along with cancer risk and believing that you are at risk.
There was a lady that Dena was working with who believed that she was going to die young from pancreatic cancer and did not take out a retirement fund or have kids. The night she received her genetic test explaining how low her risk actually was, she decided to have children!
Doctor Tommy Martin specializes in combined internal medicine and pediatrics. From his early days in residency, he's had a few encounters throughout his career that really changed his perspective on life and, even more, helped him discover his purpose. Tommy believes that sometimes patients need something medicine can't provide, the human touch.
A new cancer treatment is here, and it's better than CAR T-Cell therapy! Ricky Barrett, PhD at UPenn and biomedical scientist sits down with Sanjay Juneja to talk all about it!
Hollywood actor Cody Christian sits down with Sanjay Juneja to share his story of how cancer affected his life. Cody was 16 when his mom was diagnosed with breast cancer. Through this experience, Cody realized the importance of mental health and the need for therapists. It’s uncharted territory for everyone, and emotions run wild. So being able to talk to a professional who actually cares about the people experiencing such a traumatic event is essential.
Melanoma used to be really scary! Leading cancer researcher Keith Flaherty tells us how melanoma is actually becoming easier to treat. Keith has been working in cancer research for over 22 years, from UPenn to Mass General and Harvard Medical School. He has been one of the pioneers of immunotherapies specifically related to melanoma. In this episode, Keith and Sanjay talk about the different types of immunotherapies, why melanoma used to be so life-threatening, and how the newest treatments coming out could really change the way patients and doctors approach melanoma and cancer as a whole.
Mika Newton sits down with Dr. Sanjay Juneja, a hematologist and medical oncologist, also known as “the OncDoc” on social media. Sanjay and Mika talk about the different struggles of cancer treatments, not only from a patient perspective but from a doctor's perspective as well. Mika also brings up the importance of using your data and not letting your data just use you. After they discuss how AI can revolutionize the cancer world, Mika hands over the podcast hosting duties to Sanjay.
Dr. Mehan shares his passion to educate and empower patients.
On the Target : Cancer podcast, we talk about how technology is effectuating change in oncology.
If you are a cancer patient and want to explore your treatment options, go to http://xcures.com/options
Melody Todd shares the journey through the lens of a daughter of a cancer patient.
On the Target : Cancer podcast, we talk about how technology is effectuating change in oncology.
If you are a cancer patient and want to explore your treatment options, go to http://xcures.com/options
Jessica talks about her journey as a stage 4 Hodgkin's lymphoma survivor.
On the Target : Cancer podcast, we talk about how technology is effectuating change in oncology.
If you are a cancer patient and want to explore your treatment options, go to http://xcures.com/options
Jessica talks about her journey as a stage 4 Hodgkin's lymphoma survivor.
On the Target : Cancer podcast, we talk about how technology is effectuating change in oncology.
If you are a cancer patient and want to explore your treatment options, go to http://xcures.com/options
Part of Learning Is Sharing Experiences.
On the Target : Cancer podcast, we talk about how technology is effectuating change in oncology.
If you are a cancer patient and want to explore your treatment options, go to http://xcures.com/options
Diego was diagnosed with Colorectal cancer and talks about understanding the various challenges of his diagnosis and the one's body speaks(figuratively speaking) with oneself when sick.
On the Target : Cancer podcast, we talk about how technology is effectuating change in oncology.
If you are a cancer patient and want to explore your treatment options, go to http://xcures.com/options
Jalena talks about her diagnosis of colorectal cancer.
On the Target : Cancer podcast, we talk about how technology is effectuating change in oncology.
If you are a cancer patient and want to explore your treatment options, go to http://xcures.com/options
Paul Lauden is a cancer warrior who speaks on making the most out of life regardless of circumstance. He is a true example of a modern-day hero.
On the Target : Cancer podcast, we talk about how technology is effectuating change in oncology.
If you are a cancer patient and want to explore your treatment options, go to http://xcures.com/options
Shanie is a nurse who was diagnosed with cancer and provides a unique perspective on patient care.
On the Target : Cancer podcast, we talk about how technology is effectuating change in oncology.
If you are a cancer patient and want to explore your treatment options, go to http://xcures.com/options
Suzanne shares how she started a business after her diagnosis and the emotional journey from hearing her diagnosis to being treated.
Dr. Rosalyn Morrell is a radiation oncologist who talks about research, misinformation, and the benefits and advancements of radiation in oncology.
On the Target : Cancer podcast, we talk about how technology is effectuating change in oncology.
If you are a cancer patient and want to explore your treatment options, go to http://xcures.com/options
Dr. Seun Omofoye is a neurosurgeon who talks about the latest challenges and advancements in cancer.
On the Target : Cancer podcast, we talk about how technology is effectuating change in oncology.
If you are a cancer patient and want to explore your treatment options, go to http://xcures.com/options
Dr. Ali Afshar is a cedar sinai trained urologist who talks about kidney and bladder cancer and the various concerns of many of his patients.
On the Target : Cancer podcast, we talk about how technology is effectuating change in oncology.
If you are a cancer patient and want to explore your treatment options, go to http://xcures.com/options
Mika and Dr. HardDeep Phull talk about how technology is effectuating change in oncology.
All cancer is genetic. Only 5-10% of cancer comes from a genetic error that was inherited and the rest is from an acquired mutation.
In oncology, it's very common to get multiple opinions. There are many options out there for patients to explore.